Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Pharmacokinetic Study of 4 mg Nicotine Lozenge.: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of 4 mg Nicotine Lozenge.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01669122).
- Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function: primary endpoint results, effect estimate with confidence interval, sample-size…
- Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01517295).
- Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Intranasal Dexmedetomidine in Pediatric Patients With Congenital Heart Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03943888).
- Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa: primary endpoint results, effect estimate with confidence interval,…
- Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate…
- Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB5 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01401010).
- Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function: primary endpoint results, effect…
- Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01468558).
- Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics & Tolerability Study of MAP0004 in Smoking and Non-Smoking Adult Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl’s Solution in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pharmacokinetics and Hepatic Safety of EGCG: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Hepatic Safety of EGCG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04177693).
- Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340586).
- Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00652028).
- Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics and Safety of SAR441236: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Safety of SAR441236: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03705169).
- Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03937908).
- Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC): Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pharmacokinetics of Advantage Anti-Caries Varnish: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Advantage Anti-Caries Varnish: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04183231).
- Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04358991).
- Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03002506).
- Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03309657).
- Pharmacokinetics of Centella Asiatica in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Centella Asiatica in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03929250).
- Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00701636).
- Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00162097).
- Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00877370).